Company Filing History:
Years Active: 2016
Title: Anthony John Richardson: Innovator in TNF Modulation
Introduction
Anthony John Richardson is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate tumor necrosis factor (TNF) activity. His work is crucial for addressing various human ailments.
Latest Patents
Richardson holds a patent for "Imidazopyridine derivatives as modulators of TNF activity." This patent describes a series of imidazo[1,2-a]pyridine derivatives that serve as potent modulators of human TNFα activity. These compounds are beneficial in the treatment and prevention of a range of disorders, including autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders.
Career Highlights
Richardson is currently associated with UCB Biopharma Sprl, where he continues to innovate in the field of biopharmaceuticals. His expertise in developing therapeutic agents has positioned him as a key player in the industry.
Collaborations
Throughout his career, Richardson has collaborated with notable colleagues, including Jonathan Bentley and Daniel Christopher Brookings. These partnerships have enhanced his research and development efforts.
Conclusion
Anthony John Richardson's work in the modulation of TNF activity through innovative compounds showcases his dedication to improving human health. His contributions are vital in the ongoing fight against various diseases.